[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 3,999
Sort by:
20s Proteasome - Drugs in Development, 2021 US$ 3,500.00

20s Proteasome - Drugs in Development, 2021 SUMMARY 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by...

September 2021 76 pages
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Drugs in Development, 2021 US$ 2,000.00

Adrenoleukodystrophy (Adrenomyeloneuropathy/Schilder-Addison Complex) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleu...

September 2021 110 pages
Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 US$ 2,500.00

Amyotrophic Lateral Sclerosis (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Scle...

September 2021 945 pages
Anaphylaxis (Immunology) - Drugs in Development, 2021 US$ 2,000.00

Anaphylaxis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an...

September 2021 67 pages
Aplastic Anemia (Hematology) - Drugs in Development, 2021 US$ 2,000.00

Aplastic Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, prov...

September 2021 138 pages
Aspergillosis (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Aspergillosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aspergillosis - Drugs In Development, 2021,...

September 2021 206 pages
Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkhol...

September 2021 54 pages
C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 US$ 3,500.00

C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Drugs in Development, 2021 SUMMARY C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or C...

September 2021 126 pages
C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021 US$ 3,500.00

C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Drugs in Development, 2021 SUMMARY According to the recently published report 'C5a Anaphylatoxin Chemotactic Receptor 1 - Drugs In Developmen...

September 2021 79 pages
Cancer Pain (Central Nervous System) - Drugs in Development, 2021 US$ 2,000.00

Cancer Pain (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain - Drugs In Development, 2021,...

September 2021 169 pages
Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021 US$ 3,500.00

Catenin Beta 1 (Beta Catenin or CTNNB1) - Drugs in Development, 2021 SUMMARY Catenin Beta 1 (Beta Catenin or CTNNB1) - Catenin beta-1 or ?-catenin is a protein that is encoded by the CTNNB1 gene. In t...

September 2021 74 pages
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021 US$ 3,500.00

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Complement C5 - Drugs In Develo...

September 2021 202 pages
Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Cryptosporidiosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cryptosporidiosis - Drugs In Development...

September 2021 36 pages
Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Cytomegalovirus (HHV-5) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus Infecti...

September 2021 200 pages
Diphtheria (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Diphtheria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provid...

September 2021 93 pages
End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 US$ 2,000.00

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

September 2021 44 pages
Escherichia coli Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Escherichia coli Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections -...

September 2021 212 pages
Fanconi Anemia (Hematology) - Drugs in Development, 2021 US$ 2,000.00

Fanconi Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provid...

September 2021 93 pages
Gastritis (Gastrointestinal) - Drugs in Development, 2021 US$ 2,000.00

Gastritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides a...

September 2021 99 pages
Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021 US$ 3,500.00

Glucagon Like Peptide 2 Receptor (GLP2R) - Drugs in Development, 2021 SUMMARY Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gen...

September 2021 75 pages
Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 US$ 3,500.00

Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) - Drugs in Development, 2021 SUMMARY Glucokinase (Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2) pipeline Target constitutes close t...

September 2021 73 pages
Glycoprotein 41 (gp41) - Drugs in Development, 2021 US$ 3,500.00

Glycoprotein 41 (gp41) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitute...

September 2021 67 pages
Hepatitis B (Infectious Disease) - Drugs in Development, 2021 US$ 2,500.00

Hepatitis B (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Drugs In Development, 2021, prov...

September 2021 654 pages
Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021 US$ 2,000.00

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypereosinophilic Syndrome - Drugs In D...

September 2021 116 pages
Hypoparathyroidism (Hormonal Disorders) - Drugs in Development, 2021 US$ 2,000.00

Hypoparathyroidism (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoparathyroidism - Drugs In Developme...

September 2021 66 pages
Hypothyroidism (Hormonal Disorders) - Drugs in Development, 2021 US$ 2,000.00

Hypothyroidism (Hormonal Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Drugs In Development, 2021...

September 2021 44 pages
Impetigo (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Impetigo (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides a...

September 2021 45 pages
Insomnia (Central Nervous System) - Drugs in Development, 2021 US$ 2,000.00

Insomnia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Insomnia - Drugs In Development, 2021, provid...

September 2021 169 pages
Irritable Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 US$ 2,000.00

Irritable Bowel Syndrome (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Drugs In...

September 2021 204 pages
Leishmaniasis (Kala-Azar) (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Leishmaniasis (Kala-Azar) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Leishmaniasis - Drugs In Develop...

September 2021 139 pages
Lung Transplant Rejection (Immunology) - Drugs in Development, 2021 US$ 2,000.00

Lung Transplant Rejection (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lung Transplant Rejection - Drugs In Dev...

September 2021 101 pages
Malaria (Infectious Disease) - Drugs in Development, 2021 US$ 2,500.00

Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an...

September 2021 450 pages
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,500.00

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline gu...

September 2021 462 pages
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...

September 2021 67 pages
Migraine (Central Nervous System) - Drugs in Development, 2021 US$ 2,000.00

Migraine (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Migraine - Drugs In Development, 2021, provid...

September 2021 363 pages
Nephrotic Syndrome (Genitourinary Disorders) - Drugs in Development, 2021 US$ 2,000.00

Nephrotic Syndrome (Genitourinary Disorders) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nephrotic Syndrome - Drugs In Deve...

September 2021 64 pages
Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021 US$ 2,500.00

Parkinson's Disease (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Parkinson's Disease - Drugs In Dev...

September 2021 1584 pages
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 US$ 2,000.00

Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...

September 2021 88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 US$ 2,000.00

Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...

September 2021 53 pages
Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Drugs in Development, 2021 US$ 3,500.00

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Drugs in Development, 2021 SUMMARY Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target...

September 2021 80 pages
Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drugs in Development, 2021 US$ 3,500.00

Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Drugs in Development, 2021 SUMMARY Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Protein kinase C (PKC...

September 2021 69 pages
Schizophrenia (Central Nervous System) - Drugs in Development, 2021 US$ 2,500.00

Schizophrenia (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Drugs In Development, 20...

September 2021 513 pages
Sickle Cell Disease With Vaso-Occlusive Crisis (Hematology) - Drugs in Development, 2021 US$ 2,000.00

Sickle Cell Disease With Vaso-Occlusive Crisis (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease...

September 2021 72 pages
Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 US$ 2,000.00

Spinal Cord Injury (Central Nervous System) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury - Drugs In Devel...

September 2021 296 pages
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 US$ 2,000.00

Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 202...

September 2021 113 pages
Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 US$ 2,500.00

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Drugs...

September 2021 1013 pages
Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021 US$ 2,000.00

Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis - Drugs In Devel...

September 2021 212 pages
Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Drugs in Development, 2021 US$ 3,500.00

Transthyretin (ATTR or Prealbumin or TBPA or TTR) - Drugs in Development, 2021 SUMMARY Transthyretin (ATTR or Prealbumin or TBPA or TTR) pipeline Target constitutes close to 18 molecules. Out of which...

September 2021 128 pages
Tuberculosis (Infectious Disease) - Drugs in Development, 2021 US$ 2,500.00

Tuberculosis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis - Drugs In Development, 2021, pr...

September 2021 428 pages
Tularaemia (Infectious Disease) - Drugs in Development, 2021 US$ 2,000.00

Tularaemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provid...

September 2021 44 pages

Filters

Search

Categories

1,828
1,492
126
9
6
1
1
1
4
522
3
6

Publishers

3,999

Regions

3,999

Price

Date

Pages

Offers